FOXP3 and melanoma: It is known that melanoma is one of the main targets for immunotherapy with checkpoint inhibitors due to its high mutation load, which contributes to its high immunogenicity [1, 22], thus the study was carried out on C57Bl/6 FoxP3-EGFP mice with B16F0 melanoma.